New Findings on Hydroxychloroquine, Denosumab
Targeted Vertebral Fracture Assessment
Bisphosphonates Reduce Bone Toughness Over Time
Abaloparatide vs. Alendronate for Osteoporosis
U.S. Hip Fracture Incidence Declines with Reductions in Smoking & Drinking
Denosumab Dosing Delays Tied to Increased Fracture Risk
Bone Density Concerns: Guidance on Tackling Fracture Risk in CKD
After Hip Fracture, Earlier Osteoporosis Drug Initiation Tied to Lower Subsequent Fracture Risk
ACR Supports Bill to Establish Minimum DXA Payment
- 1
- 2
- 3
- …
- 7
- Next Page »